Diagnosis

Trigeminal neuralgia

A chronic pain condition affecting the trigeminal nerve characterized by sudden episodes of intense brief pain similar to an electric shock on one side of the face.

Also known as: Fothergill disease, Suicide disease, Tic douloureux, Trifacial neuralgia

Etiology

Cause

Pathophysiology [29y]

  1. The trigeminal nerve is responsible for the sensory and motor supply of the face

    • Ophthalmic (V1): eye, upper eyelid, and forehead

    • Maxillary (V2): lower eyelid, cheek, nostril, upper lip, and upper gingivae

    • Mandibular (V3): lower lip, lower gingivae, jaw, and the muscles of mastication

  2. Trigeminal nerve compression --> subsequent nerve demyelination

  3. Hypothesis: ectopic impulse generation induced by the demyelinated lesion without using synapses or neurotransmitters

  4. Light tactile stimulation --> Shock-like pains in the facial trigger zone

Complications [29y]

Epidemiology

Incidence per 100.000 [5t5][ieh][woe]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

None listed.

Clinical findings

None listed.

Anamneses

None listed.

Localized findings

Pain
Radiates
Caput
Onset
Hyperacute (seconds)Acute (minutes)
Pattern
Intermittent
Provoked by
Palpation
Quality
SharpStabbingBurning
Severity
Moderate (4-7)Severe (8-10)

Approach

Clinical diagnosis

The diagnostic criteria established by the ICHD-3 [29y]

  1. Recurrent paroxysms of unilateral facial pain in the distribution of the trigeminal nerve

  2. Pain has all the following characteristics:

    • Pain lasting a fraction of a second to about 2 minutes

    • Pain with severe intensity

    • Electric shock-like, sharp, or shooting pain 

  3. Innocuous stimuli within the affected nerve distribution precipitate the pain

  4. No alternative ICHD-3 diagnosis better explains the symptoms.

Treatment

  1. Anticonvulsant medicines: assessments of therapy 2 weeks after initiation

    • 1st line: Carbamazepine or oxcarbazepine [29y]

    • 2nd line: Gabapentin, clonazepam, lamotrigine, phenytoin, and valproic acid

  2. Other medications: Baclofen and Botulinum toxin A

  3. Surgery:

    • Microvascular decompression

    • Rhizotomy (rhizolysis)

    • Peripheral neurectomy and nerve blockade

    • Deep brain stimulation

    • Radiosurgery

Differential diagnoses

Cerebral aneurysm, Cluster headache, Dental infection, Herpes zoster, Intracranial hemorrhage, Migraine, Multiple sclerosis, Subarachnoid hemorrhage, Temporomandibular syndrome


References

[1] J Islam, KC Elina, YS Park. Recent update on trigeminal neuralgia. Journal of the Korean Society of Stereotactic and Functional Neurosurgery. Volume 18. Issue 1. Pages 9-19. 2022.

[2] Shankar Kikkeri N, Nagalli S. Trigeminal Neuralgia. Updated 2024 Mar 3: https://www.ncbi.nlm.nih.gov/books/NBK554486/

[3] Svedung Wettervik T, Snel D, Kristiansson P, Ericson H, Abu Hamdeh S. Incidence of trigeminal neuralgia: A population-based study in Central Sweden. Eur J Pain. 2023 May;27(5):580-587.

[4] Katusic S, Beard CM, Bergstralh E, Kurland LT. Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol. 1990 Jan;27(1):89-95.

Scroll to top